If your research focuses on zoonotic diseases, explore Abbexa's extensive product portfolio or get in touch to discuss bespoke solutions tailored to your needs.

Our range of BRCA1 products features fully validated antibodies and top-rated ELISA kits that are designed to deliver reliable, reproducible results across a variety of sample types.

See more of our cancer research essentials www.abbexa.com/products/ess...

As a result, a growing interest among researchers is the tumour microenvironment with a focus on Secreted Frizzled-Related Protein 2 (SFRP2).

What does the use of SFRP2 mean for the future direction of therapeutic strategies in TNBC? Find out in our latest article.

www.abbexa.com/The-Emergenc...

Reliable insights depend on reliable tools. Abbexa offers a wide catalogue of specific, fully validated antibodies designed to support consistent, trustworthy results, including our Mucin 21 (MUC21) Antibody.

Explore our catalogue: www.abbexa.com/products

MUC21 shows distinct expression in several tumour types, including lung adenocarcinoma, skin cancers, and brain tumours such as glioblastoma. This makes MUC21 a potential candidate for the diagnosis, treatment, and recovery outcomes, making it a key focus for ongoing oncology research.